Hong Kong-based CK Life Sciences International (Holdings) Ltd. (8222.HK) plans to spend A$10 million on biotechnology research and development in Victoria, Australia, the Australian government said Tuesday. “Our government will work closely with them to provide support, facilitation and assistance to the project, as well as help identify opportunities for R&D collaboration in Victoria,” said Victorian State Premier Steve Bracks.
